All Things Cardio-Oncology International Cardio-Oncology Society
-
- Health & Fitness
Here is a resource for expanding your understanding of the growing field of cardio-oncology in all its dimensions
-
Spotlight: Amyloidosis Trials Update - Dr. Michelle Kittleson
Dr Michelle Kittleson is Professor of Medicine at Cedars-Sinai and Director of Education in Heart Failure and Transplantation at the Smidt Heart Institute. She graduated from Harvard College and received her medical degree from Yale University. She completed residency training at Brigham and Women's Hospital and cardiology fellowship at Johns Hopkins, where she also received a PhD in Clinical Investigation.
Watch the complete webinar here: https://www.radcliffecardiology.com/webinars/latest-clinical-trial-updates-attr-cm-and-al-cm -
Cardio-Oncology Spotlight: Toxicities in Breast Cancer Therapy, Dr. Paul Cottu
Dr. Paul Cottu, oncologist at Institut Curie, Paris, FR provides an overview of breast cancer therapies with associated cardiovascular toxicities. The original webinar can be viewed at the link below:
https://www.radcliffecardiology.com/webinars/cardiotoxicity-breast-cancer-challenges-multimodal-therapies -
Cardio-Oncology Spotlight: Risk Stratification with Dr. Anne Blaes
Dr Anne Blaes is a Professor in the Division of Hematology and Oncology at the University of Minnesota. She is the Director of the Screening, Prevention, Etiology, and Cancer Survivorship (SPECS) Program within the Masonic Cancer Center.
View the original webinar here:
https://www.radcliffecardiology.com/webinars/applying-esc-ic-os-guidelines-how-do-we-actually-do-risk-stratification -
Managing Endocarditis in Patients with Cancer: Dr. Ihab Rafic Hamzeh
Ihab Rafic Hamzeh, MD, Associate Professor, Department of Cardiology, The MD Anderson Cancer Center, Houston, TX
-
Cardio-Oncology Spotlight: Cardiovascular Toxicities of Novel Cancer Drugs
This is a highlight from our weekly webinar January 11, 2023. You can view the entire broadcast at the link below.
https://www.radcliffecardiology.com/webinars/cardiovascular-toxicities-novel-cancer-drugs
Dr Kathryn Ruddy is a Professor of Oncology at Mayo Clinic, Rochester, US. She co-leads the Prevention, Survivorship and Care Delivery Programme at Mayo Clinic Comprehensive Cancer Center. -
Dr. Sarju Ganatra on SGLT2 Inhibitors and CTRCD
Dr. Ganatra and Dr. Daniel Lenihan discuss an article they both contributed to titled "SGLT2 Inhibitor Use and Risk of Clinical Events in Patients With Cancer Therapy–Related Cardiac Dysfunction"
Article Link
https://www.sciencedirect.com/science/article/abs/pii/S2213177923005966
Dr. Sarju Ganatra is Vice Chair of the Department of Medicine at Lahey Hospital Department of Medicine Research
Follow him on X:
@SarjuGanatraMD